WO2008018084A3 - Peptides dérivés d'un inhibiteur de l'activateur du plasminogène pour prévenir un dommage neuronal - Google Patents
Peptides dérivés d'un inhibiteur de l'activateur du plasminogène pour prévenir un dommage neuronal Download PDFInfo
- Publication number
- WO2008018084A3 WO2008018084A3 PCT/IL2007/001007 IL2007001007W WO2008018084A3 WO 2008018084 A3 WO2008018084 A3 WO 2008018084A3 IL 2007001007 W IL2007001007 W IL 2007001007W WO 2008018084 A3 WO2008018084 A3 WO 2008018084A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plasminogen activator
- activator inhibitor
- neuronal damage
- preventing neuronal
- peptides derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne des utilisations thérapeutiques de peptides comprenant six résidus d'acides aminés dérivés des acides aminés 350-355 de l'inhibiteur 1 de l'activateur du plasminogène humain (PAI-1) pour prévenir un dommage neuronal dû en particulier à un accident cérébrovasculaire hypoxique ou thrombo-embolique et à une lésion cérébrale.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83666506P | 2006-08-10 | 2006-08-10 | |
| US60/836,665 | 2006-08-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2008018084A2 WO2008018084A2 (fr) | 2008-02-14 |
| WO2008018084A3 true WO2008018084A3 (fr) | 2009-05-07 |
Family
ID=39033391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IL2007/001007 Ceased WO2008018084A2 (fr) | 2006-08-10 | 2007-08-12 | Peptides dérivés d'un inhibiteur de l'activateur du plasminogène pour prévenir un dommage neuronal |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008018084A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008278568B2 (en) | 2007-07-24 | 2013-08-01 | D-Pharm Ltd. | Peptides derived from plasminogen activator inhibitor-1 and uses thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6750201B1 (en) * | 1997-10-17 | 2004-06-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
-
2007
- 2007-08-12 WO PCT/IL2007/001007 patent/WO2008018084A2/fr not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6750201B1 (en) * | 1997-10-17 | 2004-06-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| US20040254115A1 (en) * | 1997-10-17 | 2004-12-16 | The Trustees Of The University Of Pennsylvania | Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008018084A2 (fr) | 2008-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200707508B (en) | 2-[isoquinolin-3-carbonyl) amino] -propionic acid derivatives as inhibitors of factors XI and IX for the treatment of thrombosis | |
| ZA201005913B (en) | Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders | |
| IL222879A (en) | Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them | |
| WO2005023866A3 (fr) | Peptides permettant d'inhiber l'activation du complement | |
| NZ593815A (en) | Tissue factor pathway inhibitor (tfpi) inhibitors and methods of use | |
| WO2006125227A3 (fr) | Composes inhibiteurs de proteines d'activation de fibroblastes et procedes | |
| WO2009100513A3 (fr) | Peptide des-[asp1hala1]- agoniste de l'angiotensine-(1-7) et compositions pharmaceutiques pour le traitement de maladies | |
| WO2005004802A3 (fr) | Inhibiteurs de la beta-secretase a base de n-alkyle phenylcarboxamide pour le traitement de la maladie d'alzheimer | |
| WO2010130832A3 (fr) | Séquences d'acides aminés dirigées contre dickkopf-1 et polypeptides comprenant ces dernières pour le traitement de maladies et de pathologies associées à la déperdition osseuse et/ou à l'ostéolyse | |
| WO2005065195A3 (fr) | Inhibiteurs de phenylamide et de pyridylamide de la beta-secretase, traitant la maladie d'alzheimer | |
| WO2007016476A3 (fr) | Inhibiteurs de la sérine protéase de l'hépatite c et emploi desdits inhibiteurs | |
| WO2007121124A3 (fr) | Composés organiques et leurs utilisations | |
| WO2008156914A3 (fr) | Peptides réplikins synthétiques contre l'infection pathogène des invertébrés en aquaculture | |
| WO2005051914A8 (fr) | Inhibiteurs de benzylether et benzylamino de beta-secretase pour traiter la maladie d'alzheimer | |
| WO2003072593A3 (fr) | Peptides ciblant les os | |
| SE0002202D0 (sv) | New peptides | |
| WO2006099610A3 (fr) | Methodes d'identification de cibles therapeutiques pour le traitement de l'atrophie vulvovaginale | |
| WO2005034889A3 (fr) | Methode pour conferer un hale artificiel a la peau humaine | |
| AU2003229284A1 (en) | Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur | |
| WO2006078576A3 (fr) | Inhibiteurs de la $g(b)-secretase d'aminomethyle dans le traitement de la maladie d'alzheimer | |
| CA2549185A1 (fr) | Peptide inhibiteur de l'enzyme de conversion de l'angiotensine | |
| WO2004050685A3 (fr) | Agents therapeutiques antifongiques | |
| WO2008018084A3 (fr) | Peptides dérivés d'un inhibiteur de l'activateur du plasminogène pour prévenir un dommage neuronal | |
| ATE531384T1 (de) | Peptide aus dem plasminogenaktivator-hemmer 1 und ihre verwendung | |
| WO2010057275A8 (fr) | Peptides cycliques et leurs utilisations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07790060 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07790060 Country of ref document: EP Kind code of ref document: A2 |